Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Paola S. Dal Cin, Ph.D.

Co-Author

This page shows the publications co-authored by Paola Dal Cin and Marisa Nucci.
Connection Strength

1.886
  1. Malignant tumours of the uterus and ovaries with Mullerian and germ cell or trophoblastic components have a somatic origin and are characterised by genomic instability. Histopathology. 2020 Nov; 77(5):788-797.
    View in: PubMed
    Score: 0.471
  2. Myxoid Leiomyosarcoma of the Uterus: A Clinicopathologic Analysis of 30 Cases and Review of the Literature With Reappraisal of Its Distinction From Other Uterine Myxoid Mesenchymal Neoplasms. Am J Surg Pathol. 2016 Mar; 40(3):285-301.
    View in: PubMed
    Score: 0.172
  3. Analysis of MDM2 Amplification in 43 Endometrial Stromal Tumors: A Potential Diagnostic Pitfall. Int J Gynecol Pathol. 2015 Nov; 34(6):576-83.
    View in: PubMed
    Score: 0.168
  4. Inflammatory myofibroblastic tumor of the uterus: clinical and pathologic review of 10 cases including a subset with aggressive clinical course. Am J Surg Pathol. 2015 Feb; 39(2):157-68.
    View in: PubMed
    Score: 0.159
  5. Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases. Am J Surg Pathol. 2014 Feb; 38(2):176-88.
    View in: PubMed
    Score: 0.149
  6. Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement. Am J Surg Pathol. 2012 Oct; 36(10):1562-70.
    View in: PubMed
    Score: 0.136
  7. The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor. Am J Surg Pathol. 2012 May; 36(5):641-53.
    View in: PubMed
    Score: 0.132
  8. Distinctive cytogenetic profile in benign metastasizing leiomyoma: pathogenetic implications. Am J Surg Pathol. 2007 May; 31(5):737-43.
    View in: PubMed
    Score: 0.093
  9. Molecular analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms. Am J Surg Pathol. 2007 Jan; 31(1):65-70.
    View in: PubMed
    Score: 0.091
  10. Fusion of the genes BRD8 and PHF1 in endometrial stromal sarcoma. Genes Chromosomes Cancer. 2017 12; 56(12):841-845.
    View in: PubMed
    Score: 0.048
  11. Involvement of Chromosome 8 in Müllerian Adenosarcoma. Int J Gynecol Pathol. 2017 Jan; 36(1):24-30.
    View in: PubMed
    Score: 0.045
  12. Intravenous leiomyomatosis: an unusual intermediate between benign and malignant uterine smooth muscle tumors. Mod Pathol. 2016 05; 29(5):500-10.
    View in: PubMed
    Score: 0.043
  13. Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract. Mod Pathol. 2015 Nov; 28(11):1504-14.
    View in: PubMed
    Score: 0.041
  14. Targeted genomic analysis of Müllerian adenosarcoma. J Pathol. 2015 Jan; 235(1):37-49.
    View in: PubMed
    Score: 0.039
  15. 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma. Proc Natl Acad Sci U S A. 2012 Jan 17; 109(3):929-34.
    View in: PubMed
    Score: 0.032
  16. HMGA1 and HMGA2 rearrangements in mass-forming endometriosis. Genes Chromosomes Cancer. 2010 Jul; 49(7):630-4.
    View in: PubMed
    Score: 0.029
  17. Ewing family of tumours involving the vulva and vagina: report of a series of four cases. J Clin Pathol. 2007 Jun; 60(6):674-80.
    View in: PubMed
    Score: 0.023
  18. Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci U S A. 2001 May 22; 98(11):6348-53.
    View in: PubMed
    Score: 0.015
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.